iifl-logo-icon 1

Concord Drugs Ltd Cash Flow Statement

36.3
(-1.89%)
Oct 22, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Concord Drugs FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

0.52

0.45

0.63

0.64

Depreciation

-1.36

-1.46

-2.4

-2.58

Tax paid

-1.01

-0.12

-0.31

-0.48

Working capital

5.74

1.76

11.4

-13.41

Other operating items

Operating

3.89

0.62

9.32

-15.83

Capital expenditure

4.24

0.19

2.27

1.05

Free cash flow

8.13

0.81

11.59

-14.78

Equity raised

29.47

26.75

23.5

19.41

Investing

0

0

0

0

Financing

3.84

-2.21

3.33

6.26

Dividends paid

0

0

0

0

Net in cash

41.45

25.35

38.42

10.88

Concord Drugs : related Articles

No Record Found

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp